Cargando…

Multiomics signatures of type 1 diabetes with and without albuminuria

AIMS/HYPOTHESIS: To identify novel pathophysiological signatures of longstanding type 1 diabetes (T1D) with and without albuminuria we investigated the gut microbiome and blood metabolome in individuals with T1D and healthy controls (HC). We also mapped the functional underpinnings of the microbiome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clos-Garcia, Marc, Ahluwalia, Tarunveer S., Winther, Signe A., Henriksen, Peter, Ali, Mina, Fan, Yong, Stankevic, Evelina, Lyu, Liwei, Vogt, Josef K., Hansen, Torben, Legido-Quigley, Cristina, Rossing, Peter, Pedersen, Oluf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755599/ https://www.ncbi.nlm.nih.gov/pubmed/36531462 http://dx.doi.org/10.3389/fendo.2022.1015557

Ejemplares similares

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria
por: Winther, Signe Abitz, et al.
Publicado: (2021)

Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes
por: Tofte, Nete, et al.
Publicado: (2019)

Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism
por: Hansen, Christian S., et al.
Publicado: (2022)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Bjerre-Christensen, Theis, et al.
Publicado: (2021)

Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus
por: Tougaard, Ninna Hahn, et al.
Publicado: (2020)

Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes
por: Tofte, Nete, et al.
Publicado: (2019)

A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria
por: Ahluwalia, Tarunveer S., et al.
Publicado: (2018)

Editorial: Novel Biomarkers for Type 2 Diabetes
por: Ahluwalia, Tarunveer S., et al.
Publicado: (2019)

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes
por: Wretlind, Asger, et al.
Publicado: (2023)

Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes
por: Al-Sari, Naba, et al.
Publicado: (2022)

Circulating Metabolomic and Lipidomic Signatures Identify a Type 2 Diabetes Risk Profile in Low-Birth-Weight Men with Non-Alcoholic Fatty Liver Disease
por: Elingaard-Larsen, Line O., et al.
Publicado: (2023)

Association of general health and lifestyle factors with the salivary microbiota – Lessons learned from the ADDITION-PRO cohort
por: Poulsen, Casper Sahl, et al.
Publicado: (2022)

Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes
por: Ferreira-Divino, Luis F., et al.
Publicado: (2022)

The Type 2 Diabetes Risk Allele of TMEM154-rs6813195 Associates with Decreased Beta Cell Function in a Study of 6,486 Danes
por: Harder, Marie Neergaard, et al.
Publicado: (2015)

Cause-Specific Mortality According to Urine Albumin Creatinine Ratio in the General Population
por: Skaaby, Tea, et al.
Publicado: (2014)

The gut microbiota in multiple sclerosis varies with disease activity
por: Thirion, Florence, et al.
Publicado: (2023)

Common variants in LEPR, IL6, AMD1, and NAMPT do not associate with risk of juvenile and childhood obesity in Danes: a case–control study
por: Hollensted, Mette, et al.
Publicado: (2015)

Describing the fecal metabolome in cryogenically collected samples from healthy participants
por: Trošt, Kajetan, et al.
Publicado: (2020)

Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study)
por: Møller, Marie, et al.
Publicado: (2023)

Patients with type 1 diabetes and albuminuria have a reduced brain glycolytic capability that is correlated with brain atrophy
por: Vestergaard, Mark B., et al.
Publicado: (2023)

Albuminuria and the Duration of Albuminuria in Cholera
por: Brahmachari, U. N.
Publicado: (1907)

Circulating Metabolites and Lipids Are Associated to Diabetic Retinopathy in Individuals With Type 1 Diabetes
por: Curovic, Viktor Rotbain, et al.
Publicado: (2020)

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria
por: Rathcke, Camilla Noelle, et al.
Publicado: (2009)

Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes
por: Stougaard, Elisabeth Buur, et al.
Publicado: (2021)

Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria
por: McGill, Janet B, et al.
Publicado: (2022)

The national child odontology registry (SCOR): a valuable resource for odontological and public health research
por: Nygaard, Nikoline, et al.
Publicado: (2023)

Multiomics and machine learning in lung cancer prognosis
por: Gao, Yanan, et al.
Publicado: (2020)

Multiomic Investigations into Lung Health and Disease
por: Blutt, Sarah E., et al.
Publicado: (2023)

Dietary ascorbic acid and subsequent change in body weight and waist circumference: associations may depend on genetic predisposition to obesity - a prospective study of three independent cohorts
por: Larsen, Sofus C, et al.
Publicado: (2014)

Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study
por: Gæde, Peter, et al.
Publicado: (2019)

Assessment of the sublingual microcirculation with the GlycoCheck system: Reproducibility and examination conditions
por: Eickhoff, Mie Klessen, et al.
Publicado: (2020)

The drivers of non-adherence to albuminuria testing guidelines and the clinical and economic impact of not identifying chronic kidney disease
por: Groehl, Franziska, et al.
Publicado: (2023)

Multiomics, Artificial Intelligence and Precision Medicine in Perinatology
por: Pammi, Mohan, et al.
Publicado: (2023)

Editorial: The Role of Genetic and Lifestyle Factors in Metabolic Diseases
por: Ahmad, Shafqat, et al.
Publicado: (2019)

Albuminuria
Publicado: (1890)

Albuminuria
por: Ballenger, Edgar
Publicado: (1908)

Albuminuria
Publicado: (1883)

Albuminuria
por: Reed, W. L.
Publicado: (1893)

Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018)

The gut microbiome in cardio-metabolic health
por: Hansen, Tue H, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g5aj1ea57kobdcibbaa8abost6